🚀 VC round data is live in beta, check it out!

Fangzhou Valuation Multiples

Discover revenue and EBITDA valuation multiples for Fangzhou and similar public comparables like 1-800-Flowers.com, Oponeo, Nelly Group, Kogan.com and more.

Fangzhou Overview

About Fangzhou

Fangzhou Inc is a online chronic disease management platform in China. It has focus on chronic disease management to address the needs of patients with chronic diseases, such as hypertension, cardiovascular and respiratory chronic diseases. The company provide comprehensive medical services and online retail pharmacy services through Jianke Platform. The principal segment of the group are online retail pharmacy services, comprehensive medical services, Wholesale and customized content and marketing solutions. Key revenue is generated from Online retail pharmacy services.


Founded

2019

HQ

China

Employees

488

Financials (LTM)

Revenue: $561M
EBITDA: $6M

EV

$212M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Fangzhou Financials

Fangzhou reported last 12-month revenue of $561M and EBITDA of $6M.

In the same LTM period, Fangzhou generated $92M in gross profit, $6M in EBITDA, and $3M in net income.

Revenue (LTM)


Fangzhou P&L

In the most recent fiscal year, Fangzhou reported revenue of $397M and EBITDA of ($121M).

Fangzhou expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Fangzhou forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$561MXXX$397MXXXXXXXXX
Gross Profit$92MXXX$76MXXXXXXXXX
Gross Margin16%XXX19%XXXXXXXXX
EBITDA$6MXXX($121M)XXXXXXXXX
EBITDA Margin1%XXX(31%)XXXXXXXXX
EBIT Margin1%XXX(28%)XXXXXXXXX
Net Profit$3MXXX($125M)XXXXXXXXX
Net Margin0%XXX(32%)XXXXXXXXX

Financial data powered by Morningstar, Inc.

Fangzhou Stock Performance

Fangzhou has current market cap of $253M, and enterprise value of $212M.

Market Cap Evolution


Fangzhou's stock price is $0.18.

See Fangzhou trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$212M$253M3.0%XXXXXXXXX$-0.09

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Fangzhou Valuation Multiples

Fangzhou trades at 0.4x EV/Revenue multiple, and 37.9x EV/EBITDA.

See valuation multiples for Fangzhou and 15K+ public comps

EV / Revenue (LTM)


Fangzhou Financial Valuation Multiples

As of April 19, 2026, Fangzhou has market cap of $253M and EV of $212M.

Equity research analysts estimate Fangzhou's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Fangzhou has a P/E ratio of 94.8x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$253MXXX$253MXXXXXXXXX
EV (current)$212MXXX$212MXXXXXXXXX
EV/Revenue0.4xXXX0.5xXXXXXXXXX
EV/EBITDA37.9xXXX(1.7x)XXXXXXXXX
EV/EBIT69.7xXXX(1.9x)XXXXXXXXX
EV/Gross Profit2.3xXXX2.8xXXXXXXXXX
P/E94.8xXXX(2.0x)XXXXXXXXX
EV/FCF—XXX92.7xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Fangzhou Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Fangzhou Margins & Growth Rates

Fangzhou's revenue in the last 12 month grew by 33%.

Fangzhou's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.4M for the same period.

Fangzhou's rule of 40 is 34% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Fangzhou's rule of X is 82% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Fangzhou and other 15K+ public comps

Fangzhou Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth33%XXX29%XXXXXXXXX
EBITDA Margin1%XXX(31%)XXXXXXXXX
EBITDA Growth136%XXX(103%)XXXXXXXXX
Rule of 40—XXX34%XXXXXXXXX
Bessemer Rule of X—XXX82%XXXXXXXXX
Revenue per Employee—XXX$0.8MXXXXXXXXX
Opex per Employee—XXX$0.4MXXXXXXXXX
S&M Expenses to Revenue11%XXX13%XXXXXXXXX
G&A Expenses to Revenue4%XXX34%XXXXXXXXX
Opex to Revenue—XXX47%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Fangzhou Public Comps

See public comps and valuation multiples for other Consumer E-commerce and Pharmacies comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
FangzhouXXXXXXXXXXXXXXXXXX
1-800-Flowers.comXXXXXXXXXXXXXXXXXX
OponeoXXXXXXXXXXXXXXXXXX
Nelly GroupXXXXXXXXXXXXXXXXXX
Kogan.comXXXXXXXXXXXXXXXXXX
ScrollXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Fangzhou M&A Activity

Fangzhou acquired XXX companies to date.

Last acquisition by Fangzhou was on XXXXXXXX, XXXXX. Fangzhou acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Fangzhou

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Fangzhou Investment Activity

Fangzhou invested in XXX companies to date.

Fangzhou made its latest investment on XXXXXXXX, XXXXX. Fangzhou invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Fangzhou

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Fangzhou

When was Fangzhou founded?Fangzhou was founded in 2019.
Where is Fangzhou headquartered?Fangzhou is headquartered in China.
How many employees does Fangzhou have?As of today, Fangzhou has over 488 employees.
Who is the CEO of Fangzhou?Fangzhou's CEO is Fangmin Xie.
Is Fangzhou publicly listed?Yes, Fangzhou is a public company listed on HKEX.
What is the stock symbol of Fangzhou?Fangzhou trades under 06086 ticker.
When did Fangzhou go public?Fangzhou went public in 2024.
Who are competitors of Fangzhou?Fangzhou main competitors are 1-800-Flowers.com, Oponeo, Nelly Group, Kogan.com.
What is the current market cap of Fangzhou?Fangzhou's current market cap is $253M.
What is the current revenue of Fangzhou?Fangzhou's last 12 months revenue is $561M.
What is the current revenue growth of Fangzhou?Fangzhou revenue growth (NTM/LTM) is 33%.
What is the current EV/Revenue multiple of Fangzhou?Current revenue multiple of Fangzhou is 0.4x.
Is Fangzhou profitable?Yes, Fangzhou is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Fangzhou?Fangzhou's last 12 months EBITDA is $6M.
What is Fangzhou's EBITDA margin?Fangzhou's last 12 months EBITDA margin is 1%.
What is the current EV/EBITDA multiple of Fangzhou?Current EBITDA multiple of Fangzhou is 37.9x.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial